Eli Lilly's Taltz-Zepbound combination achieved significant improvements in two Phase 3b trials for plaque psoriasis and psoriatic arthritis with obesity. Combo therapy led to complete skin clearance and weight loss in psoriasis, and rapid disease activity reduction in psoriatic arthritis. The results were presented at AAD 2026.
President Trump signed a spending package funding the National Institutes of Health at nearly $49 billion, the highest level ever, reversing his earlier push for a 40% budget cut to medical research.
The Trump administration launched TrumpRx.gov in February 2026, offering discounted prices on dozens of brand-name prescription drugs through negotiated deals with pharmaceutical companies, though critics warn many listed drugs have cheaper generic alternatives.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07772869 |
Uterine Lavage to Detect Ovarian Cancer Risk |
NOT_YET_RECRUITING | NA |
| NCT07731802 |
Finasteride and Cutibacterium |
NOT_YET_RECRUITING | PHASE4 |
| NCT07731789 |
Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma |
NOT_YET_RECRUITING | PHASE2 |
| NCT07725679 |
A Hybrid Effectiveness-Implementation Trial of Urine Point-of-Care Assay to Increase PrEP Adherence Among Women in Kenya |
NOT_YET_RECRUITING | NA |
| NCT07723599 |
Combating Age-related Failure of Myelination in Multiple Sclerosis: An Exploratory Study |
NOT_YET_RECRUITING | |
| NCT07721259 |
A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden |
NOT_YET_RECRUITING | PHASE2 |
| NCT07718971 |
UW ISeqU: Clinical Impact of Whole-genome Sequencing in Adults |
ENROLLING_BY_INVITATION | |
| NCT07699380 |
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) |
RECRUITING | PHASE2 |
| NCT07698535 |
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial |
NOT_YET_RECRUITING | PHASE2 |
| NCT07686159 |
Evaluation of Mosquito Repellent Products' Efficacy, Safety, and Public Health Implications |
COMPLETED | NA |
